Related Experiment Video
Updated: Jul 15, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53: guardian of the genome and policeman of the oncogenes
1Tumor Suppression Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Abstract:
The process of malignant transformation universally entails genetic damage and oncogenic signaling, two stresses that are signaled to p53 through different genetic pathways. Based on this, it is possible to distinguish two jobs for p53: "guardian of the genome" that consists in sensing and reacting to DNA damage through the ATM/ATR and Chk1/Chk2 kinases, and "policeman of the oncogenes" that, correspondingly, consists in responding to oncogenic signaling through the p53-stabilizing protein ARF. Contrary to expectation, recent genetic evidence in mice indicates that the response of p53 to DNA damage has little or no impact on cancer protection. In contrast, ARF-dependent activation of p53 is critical for p53-mediated tumor suppression. Here, we discuss the mechanistic implications of these observations and their relevance for cancer therapy.
Insights
The tumor suppressor protein p53 has two roles: guardian of the genome and policeman of oncogenes. Evidence shows the ARF-dependent pathway, not DNA damage response, is crucial for p53
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Malignant transformation involves genetic damage and oncogenic signaling, activating the p53 protein via distinct pathways.
- p53's functions are categorized as "guardian of the genome" (DNA damage response) and "policeman of oncogenes" (oncogenic signaling response).
- The DNA damage response involves ATM/ATR and Chk1/Chk2 kinases, while oncogenic signaling response involves p14ARF (ARF).
Purpose of the Study:
- To investigate the distinct roles of p53's "guardian" and "policeman" functions in cancer suppression.
- To analyze the mechanistic implications of p53's response to DNA damage versus oncogenic signaling.
- To evaluate the relevance of these findings for developing novel cancer therapies.
Main Methods:
- Analysis of recent genetic evidence from mouse models.
- Comparative study of p53's response pathways to DNA damage and oncogenic signaling.
- Discussion of mechanistic insights and therapeutic relevance.
Main Results:
- Contrary to expectations, p53's response to DNA damage has minimal impact on cancer protection in mice.
- ARF-dependent activation of p53 is critical for effective tumor suppression mediated by p53.
- These findings highlight the differential importance of p53's activation pathways.
Conclusions:
- The "policeman of the oncogenes" role of p53, mediated by ARF, is more critical for tumor suppression than the "guardian of the genome" role.
- Understanding these distinct roles provides mechanistic insights into cancer development.
- These insights have significant implications for the development of targeted cancer therapies.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Positive Regulator Molecules
Positive Regulator Molecules

